Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2012
12/26/2012CN102836118A Sustained-release analgesic drug
12/26/2012CN102835657A Lactic acid bacteria-containing food composition and pharmaceutical composition used for inhibiting inflammatory response and resisting vaginitis
12/26/2012CN102835532A Mint and mung bean coating tea
12/26/2012CN102274393B Medicament for treating cold and preparation method thereof
12/26/2012CN102274320B Externally-applied heat-reducing medicinal liquor and use thereof
12/26/2012CN102266541B Chinese medicinal plaster for treating hyperosteogeny or hyperosteogeny pain
12/26/2012CN102266459B Chinese medicinal spray for eliminating trauma gall and preparation method
12/26/2012CN102204957B Liquid medicine for external use for treating exogenous wind-cold type common cold of children
12/26/2012CN102188388B Diclofenac sodium sustained-release pellet preparation and preparation method thereof
12/26/2012CN102058641B Detection method of angelica dahurica, extract and pharmaceutical composition containing angelica dahurica extract
12/26/2012CN101972220B Medicated toothpaste
12/26/2012CN101721444B Saussurea involucrate self-micro-emulsion, preparation method thereof and application thereof
12/26/2012CN101437799B p38 MAP kinase inhibitors
12/26/2012CN101304978B Quinazoline derivatives as a multiplex inhibitor, pharmaceutical composition and uses thereof
12/26/2012CN101139392B KDR peptides and vaccines containing the same
12/26/2012CN100998864B Cyclosporin A semisolid skeleton capsule
12/25/2012US8338591 3-aryl-5,6-disubstituted pyridazines
12/25/2012US8338474 Use of phthalimide and/or sulphonamide derivatives in the treatment of diseases which require reducing the TNF-α levels and an exogenous source of nitric oxide, phthalimide derivatives, sulphonamide derivatives, and a method for obtaining a sulphonamide derivative
12/25/2012US8338431 Phosphodiesterase inhibitors
12/25/2012US8338367 Fused heteroaryl diamide compounds useful as MMP-13 inhibitors
12/25/2012US8337829 Conditioned medium and proliferated cell lines produced therefrom
12/25/2012US8337816 Comprising inhalable medicament particles having a mass median aerodynamic diameter no greater than 10 mu m and 50% of a non-respirable excipient fraction comprising low density excipient particles having an aerodynamic diameter greater than 10 mu m and a geometric diameter greater than 30 mu m
12/20/2012WO2012174362A1 Pyrazole derivatives as cannabinoid receptor 1 antagonists
12/20/2012WO2012174013A2 Treatment of cardiovascular disease, stroke, and inflammatory conditions
12/20/2012WO2012173987A2 Methods of treatment using a bcat1 inhibitor
12/20/2012WO2012172411A1 Therapeutic application of parenteral krill oil
12/20/2012WO2012171863A1 New selective ccr2 antagonists
12/20/2012WO2012171488A1 Coumarin derivative, pharmaceutical composition and use thereof
12/20/2012WO2012111934A3 Pharmaceutical composition for preventing and treating inflammatory disease or asthma containing an extract of decaspermum fruticosum
12/20/2012WO2012106463A3 Cardiotrophin related molecules for enhanced therapeutics
12/20/2012US20120323178 Bepotastine compositions
12/20/2012US20120322877 (bis)urea and (bis)thiorea compounds as eipgenic modulators of lysine-specific demethylase 1 and methods of treating disorders
12/20/2012US20120322874 Pharmaceutical Uses
12/20/2012US20120322860 Aptamer therapeutics useful in the treatment of complement-related disorders
12/20/2012US20120322856 Method for Promoting Angiogenesis, Vascularization, or Vessel Repair or for the Inhibiting Tumor Angiogenesis
12/20/2012US20120322853 Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene
12/20/2012US20120322840 Transdermally Absorbable Preparation Containing Basic Anti-Inflammatory Analgesic
12/20/2012US20120322838 Epothilone Compounds, Preparation Method and Use Thereof
12/20/2012US20120322828 Methods for controlling pain in equines using a transdermal solution of fentanyl
12/20/2012US20120322815 Pharmaceutical composition containing a3 adenosine receptor agonist
12/20/2012US20120322810 New salts
12/20/2012US20120322806 Quinoxalinedione derivatives
12/20/2012US20120322802 Novel 2, 4-pyrimidine derivatives and use thereof
12/20/2012US20120322801 Heterocyclic amides as rock inhibitors
12/20/2012US20120322800 Sepiapterin Reductase Inhibitors For The Treatment of Pain
12/20/2012US20120322795 Biarylamide inhibitors of leukotriene production
12/20/2012US20120322790 Pyrazolopiperidine Compounds As CCR1 Receptor Antagonists
12/20/2012US20120322788 Compouds
12/20/2012US20120322776 Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
12/20/2012US20120322746 Methods, compositions, and kits for the treatment of ophthalmic disorders
12/20/2012US20120322744 Poly-pegylated protease inhibitors
12/20/2012US20120322722 Pyruvamide Compounds as Inhibitors of Dust Mite Group 1 Peptidase Allergen and Their Use
12/20/2012US20120322100 Methods for producing modified glycoproteins
12/20/2012US20120322024 Strip for the delivery of oral care compositions
12/20/2012US20120321720 Therapeutic application of parenteral krill oil
12/20/2012US20120321710 Controlled Release and Taste Masking Oral Pharmaceutical Composition
12/20/2012US20120321698 Inhalable pharmaceutical compositions
12/20/2012US20120321693 Prg4 treatment for interstitial cystitis
12/20/2012US20120321692 Methods and Dressings for Sealing Internal Injuries
12/20/2012US20120321691 Clay-based hemostatic agents and devices for the delivery thereof
12/20/2012US20120321685 Compositions containing oils having a specific gravity higher than the specific gravity of water
12/20/2012US20120321678 Intra-articularly supplementation method for treating joint diseases and injuries
12/20/2012US20120321673 Transdermal drug delivery system and method of using the same
12/20/2012US20120321668 PEPTIDES DERIVED FROM HIV-1 gp41 TRANSMEMBRANE
12/20/2012US20120321652 Peptides for active anti-cytokine immunization
12/20/2012US20120321631 Anti-inflammatory agents
12/20/2012US20120321629 Stem cell factor inhibitor
12/20/2012US20120321603 Composition and method for stabilization and delivery of therapeutic molecules
12/20/2012US20120321600 Infant formula with probiotics and milk fat globule membrane components
12/20/2012US20120321597 Methods and compositions for regenerating connective tissue
12/20/2012US20120321590 Bridged polycyclic compounds
12/20/2012US20120321575 Use of kif13a and ap-1 inhibitors for inhibiting melanogenesis
12/20/2012US20120321573 Compositions and methods of prophylaxis for contact dermatitis
12/20/2012US20120321565 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist
12/20/2012US20120321563 Carbonic Anhydrase Targeting Agents and Methods of Using Same
12/20/2012US20120321554 Plexin d1 as a target for tumor diagnosis and therapy
12/20/2012CA2838952A1 Anti-psgl-1 antibodies and uses thereof
12/20/2012CA2838312A1 Therapeutic application of parenteral krill oil
12/19/2012EP2535413A2 Splice switching oligomers for the TNF superfamily receptors and their use in treatment of disease
12/19/2012EP2535410A1 Aptamer to fgf2 and use thereof
12/19/2012EP2535332A1 Sinomenine derivatives, synthetic methods and uses thereof
12/19/2012EP2534158A1 Benzylpyrrolidinone derivatives as modulators of chemokine receptor activity
12/19/2012EP2534151A1 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds
12/19/2012EP2534149A1 6-amino-2-{ [ (1s)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate
12/19/2012EP2534148A1 Purine derivatives and their pharmaceutical uses
12/19/2012EP2534137A1 Pyridazine derivatives useful as cannabinoid - 2 agonists
12/19/2012EP2533799A2 Methods for the use of progestogen as a glucocorticoid sensitizer
12/19/2012EP2533782A1 PIPERAZINE DERIVATIVES FOR BLOCKING Cav2.2 CALCIUM CHANNELS
12/19/2012CN202605346U Perforated adhesive plaster
12/19/2012CN202605345U Beeswax mud plaster
12/19/2012CN202605099U Moxibustion paster
12/19/2012CN102834506A Method for producing regulatory dendritic cells
12/19/2012CN102834388A Cgrp receptor antagonist
12/19/2012CN102834380A Inhibitors of protein kinases
12/19/2012CN102827280A Anti-IL-13 antibodies and use thereof
12/19/2012CN102827256A Preparation and application of ginseng glycoprotein
12/19/2012CN102827253A Micro-molecular polypeptide inhibiting inflammatory response, and application thereof
12/19/2012CN102827167A Octahydro-pyrrolo[3,4-b]pyrrole derivatives and use of octahydro-pyrrolo[3,4-b]pyrrole derivatives as histamine-3 receptor
12/19/2012CN102827081A Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor
12/19/2012CN102827039A Herba Houttuyniae derivative and its application in drugs
1 ... 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 ... 1272